HRP20090112T3 - 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence - Google Patents
2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinenceInfo
- Publication number
- HRP20090112T3 HRP20090112T3 HR20090112T HRP20090112T HRP20090112T3 HR P20090112 T3 HRP20090112 T3 HR P20090112T3 HR 20090112 T HR20090112 T HR 20090112T HR P20090112 T HRP20090112 T HR P20090112T HR P20090112 T3 HRP20090112 T3 HR P20090112T3
- Authority
- HR
- Croatia
- Prior art keywords
- alk
- halo
- cycloalk
- ylsulfanyl
- ylsulfonyl
- Prior art date
Links
- -1 1h-indolylsulfanyl Chemical group 0.000 title 1
- 208000019022 Mood disease Diseases 0.000 title 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58855504P | 2004-07-16 | 2004-07-16 | |
| DKPA200401121 | 2004-07-16 | ||
| US69173605P | 2005-06-17 | 2005-06-17 | |
| DKPA200500893 | 2005-06-17 | ||
| PCT/DK2005/000491 WO2006007843A1 (en) | 2004-07-16 | 2005-07-13 | 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090112T3 true HRP20090112T3 (en) | 2009-03-31 |
Family
ID=39243745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090112T HRP20090112T3 (en) | 2004-07-16 | 2009-02-23 | 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7678800B2 (uk) |
| EP (1) | EP1771415B1 (uk) |
| JP (1) | JP4865710B2 (uk) |
| KR (1) | KR20070036061A (uk) |
| CN (1) | CN1972911A (uk) |
| AR (1) | AR052308A1 (uk) |
| AT (1) | ATE420071T1 (uk) |
| AU (1) | AU2005263324A1 (uk) |
| BR (1) | BRPI0512073A (uk) |
| CA (1) | CA2570805C (uk) |
| CY (1) | CY1108942T1 (uk) |
| DE (1) | DE602005012272D1 (uk) |
| DK (1) | DK1771415T3 (uk) |
| EA (1) | EA011418B1 (uk) |
| ES (1) | ES2317266T3 (uk) |
| HR (1) | HRP20090112T3 (uk) |
| IL (1) | IL179924A0 (uk) |
| MX (1) | MXPA06015201A (uk) |
| NO (1) | NO20066010L (uk) |
| PL (1) | PL1771415T3 (uk) |
| PT (1) | PT1771415E (uk) |
| RS (1) | RS50804B (uk) |
| SI (1) | SI1771415T1 (uk) |
| UA (1) | UA82610C2 (uk) |
| WO (1) | WO2006007843A1 (uk) |
| ZA (1) | ZA200610162B (uk) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| MX2008016008A (es) * | 2006-06-16 | 2009-01-16 | Lundbeck & Co As H | Formas cristalinas de 4-[2-(4-metilfenilsulfonil)-fenil] piperidina con inhibicion combinada de la recaptacion de serotonina y norepinefrina para el tratamiento del dolor neuropatico. |
| TWI432194B (zh) * | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途 |
| CA2729635A1 (en) * | 2008-07-03 | 2010-01-07 | Ananth Srinivasan | Compounds and processes for production of radiopharmaceuticals |
| AU2014349184A1 (en) * | 2013-11-14 | 2015-11-12 | California Institute Of Technology | Accommodating intraocular lens |
| JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． | 芳香族複素環式化合物及び医薬におけるその応用 |
| EP3166924B1 (en) | 2014-07-08 | 2019-02-20 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| CN108536644B (zh) * | 2015-12-04 | 2022-04-12 | 格兰菲智能科技有限公司 | 由装置端推核心入队列的装置 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| US4241071A (en) | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
| US4198417A (en) | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
| DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
| EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
| GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| US6645969B1 (en) | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| ES2143992T3 (es) * | 1991-11-25 | 2000-06-01 | Pfizer | Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas. |
| GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
| GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
| EP0755923B1 (en) | 1995-01-23 | 2005-05-04 | Daiichi Suntory Pharma Co., Ltd. | Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| ES2128281T1 (es) | 1995-11-06 | 1999-05-16 | Gist Brocades Bv | Proceso de desesterificacion. |
| CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
| US5912256A (en) | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| ES2188970T3 (es) | 1996-08-27 | 2003-07-01 | Wyeth Corp | 4-aminoetoxiindoles, como agonistas d2 de dopamina y como ligandos de los receptores 5ht1a. |
| GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
| DE19756036A1 (de) | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
| US6333146B1 (en) | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
| NZ515238A (en) | 1999-04-02 | 2005-02-25 | Icos Corp | Inhibitors of LFA-1 binding to ICAMs and uses thereof |
| DE69930381T2 (de) | 1999-04-30 | 2006-12-07 | Trustees Of The University Of Pennsylvania | Spect abbildungsreagenzien für serotonintransporter |
| JP2003528810A (ja) | 1999-08-04 | 2003-09-30 | ミレニアム ファーマスーティカルズ インク | メラノコルチン−４受容体結合化合物及びその使用方法 |
| EE200200191A (et) | 1999-10-13 | 2003-06-16 | Pfizer Products Inc. | Monoamiini taasomastamise inhibiitoritena kasulikud biarüüleetri derivaadid |
| US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| PT1246816E (pt) | 1999-12-30 | 2004-08-31 | Lundbeck & Co As H | Derivados de fenilpiperazina substituidos sua preparacao e utilizacao |
| KR20020067589A (ko) | 1999-12-30 | 2002-08-22 | 하. 룬트벡 아크티에 셀스카브 | 페닐피페라지닐 유도체 |
| WO2001049679A1 (en) | 1999-12-30 | 2001-07-12 | H. Lundbeck A/S | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| DE60129420T2 (de) | 2000-02-29 | 2008-04-03 | MediQuest Therapeutics, Inc., Bothell | Melanocyt-tyrosinase hemmer als topische hautdepigmentierende mittel |
| KR20020097484A (ko) | 2000-05-19 | 2002-12-31 | 다케다 야쿠힌 고교 가부시키가이샤 | β-씨크리타아제 억제제 |
| US6455738B1 (en) | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| CA2416384A1 (en) | 2000-07-17 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Sulfone derivatives, their production and use |
| AU2001279955A1 (en) | 2000-08-18 | 2002-03-04 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
| HUP0500470A3 (en) | 2000-09-01 | 2005-11-28 | Fmc Corp | 1,4-disubstituted benzenes as insecticides and use thereof |
| AU2001288623A1 (en) | 2000-09-05 | 2002-03-22 | Tularik, Inc. | Fxr modulators |
| EP1193268A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| AU2001292092A1 (en) | 2000-10-06 | 2002-04-15 | Biocompatibles Uk Limited | Zwitterionic polymers |
| AU2002213467A1 (en) | 2000-10-11 | 2002-04-22 | Chemocentryx, Inc. | Modulation of ccr4 function |
| RU2288719C2 (ru) | 2000-11-14 | 2006-12-10 | Мерк Патент Гмбх | Применение соединения, сочетающего свойства ингибитора обратного захвата серотонина и агониста 5-нт1a рецептора |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
| US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
| WO2002062766A2 (en) | 2001-02-07 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| DE60218037T2 (de) * | 2001-06-07 | 2007-08-23 | F. Hoffmann-La Roche Ag | Neue indolderivate mit affinität zum 5-ht6-rezeptor |
| EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| US7064139B2 (en) | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
| JP2005509032A (ja) | 2001-11-14 | 2005-04-07 | シェーリング コーポレイション | カンナビノイドレセプターリガンド |
| IL162308A0 (en) | 2001-12-21 | 2005-11-20 | Lundbeck & Co As H | Aminoindane derivatives as serotonin and norepinephrine uptakeinhibitors |
| ATE371680T1 (de) | 2002-01-16 | 2007-09-15 | Biocompatibles Uk Ltd | Polymerkonjugate |
| US20050261298A1 (en) | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
| WO2003074538A1 (fr) | 2002-03-04 | 2003-09-12 | Japan Science And Technology Agency | Nouveaux phosphonamides, procede de production correspondant, et utilisation associee |
| US7700200B2 (en) | 2002-03-29 | 2010-04-20 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
| DE10217006A1 (de) | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| EP1539693B9 (en) | 2002-06-19 | 2008-10-08 | Schering Corporation | Cannabinoid receptor agonists |
| TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| MXPA05002696A (es) | 2002-09-17 | 2005-05-05 | Hoffmann La Roche | Indoles 2,7-sustituidos y su uso como moduladores de 5-hidroxitriptamina 6 (5-ht6). |
| JP4267573B2 (ja) | 2002-09-17 | 2009-05-27 | エフ．ホフマン−ラ ロシュ アーゲー | ２，４−置換インドールおよびそれらの５−ｈｔ６モジュレーターとしての使用 |
| EP1402888A1 (en) | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
| US20040266732A1 (en) | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
| WO2004035047A1 (en) * | 2002-10-18 | 2004-04-29 | F. Hoffmann-La Roche Ag | 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| US20040137389A1 (en) | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
| EA011087B1 (ru) | 2002-12-20 | 2008-12-30 | Эмджен Инк. | Соединения и фармацевтические композиции для лечения воспалительных заболеваний |
| US7189501B2 (en) | 2002-12-27 | 2007-03-13 | Fuji Photo Film Co., Ltd. | Silver halide color photographic photosensitive material |
| DE10300098A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
| US7820753B2 (en) | 2003-02-05 | 2010-10-26 | Biocompatibles Uk Limited | Block copolymers |
| TW200505902A (en) | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| CA2520124A1 (en) | 2003-03-28 | 2004-10-14 | Chiron Corporation | Use of benzazole compounds for immunopotentiation |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| US20070060595A1 (en) | 2003-10-10 | 2007-03-15 | Toshio Yoshizawa | Novel fused heterocyclic compound and use thereof |
| US7229751B2 (en) | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
| MXPA06007054A (es) | 2003-12-19 | 2007-04-17 | Elixir Pharmaceuticals Inc | Metodos para tratar una enfermedad. |
| PT1701940E (pt) * | 2003-12-23 | 2008-07-30 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-benzil-amina como ssri |
| SE528250C2 (sv) | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
| JP4569142B2 (ja) | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
| JP4448730B2 (ja) | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
| WO2006006172A2 (en) | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
| WO2006098380A1 (ja) | 2005-03-15 | 2006-09-21 | Fujifilm Corporation | 円盤状化合物を用いた表面処理法、表面処理用（潤滑）組成物及び表面処理された物品 |
-
2005
- 2005-07-12 AR ARP050102877A patent/AR052308A1/es not_active Application Discontinuation
- 2005-07-13 PT PT05759183T patent/PT1771415E/pt unknown
- 2005-07-13 EA EA200602180A patent/EA011418B1/ru not_active IP Right Cessation
- 2005-07-13 BR BRPI0512073-0A patent/BRPI0512073A/pt not_active IP Right Cessation
- 2005-07-13 US US11/629,043 patent/US7678800B2/en not_active Expired - Fee Related
- 2005-07-13 KR KR1020067025769A patent/KR20070036061A/ko not_active Application Discontinuation
- 2005-07-13 CN CNA200580020862XA patent/CN1972911A/zh active Pending
- 2005-07-13 RS RSP-2009/0070A patent/RS50804B/sr unknown
- 2005-07-13 DE DE602005012272T patent/DE602005012272D1/de active Active
- 2005-07-13 UA UAA200612493A patent/UA82610C2/uk unknown
- 2005-07-13 DK DK05759183T patent/DK1771415T3/da active
- 2005-07-13 ES ES05759183T patent/ES2317266T3/es active Active
- 2005-07-13 SI SI200530606T patent/SI1771415T1/sl unknown
- 2005-07-13 JP JP2007520664A patent/JP4865710B2/ja not_active Expired - Fee Related
- 2005-07-13 AU AU2005263324A patent/AU2005263324A1/en not_active Abandoned
- 2005-07-13 WO PCT/DK2005/000491 patent/WO2006007843A1/en active Application Filing
- 2005-07-13 EP EP05759183A patent/EP1771415B1/en active Active
- 2005-07-13 ZA ZA200610162A patent/ZA200610162B/en unknown
- 2005-07-13 AT AT05759183T patent/ATE420071T1/de active
- 2005-07-13 MX MXPA06015201A patent/MXPA06015201A/es not_active Application Discontinuation
- 2005-07-13 PL PL05759183T patent/PL1771415T3/pl unknown
- 2005-07-13 CA CA2570805A patent/CA2570805C/en not_active Expired - Fee Related
-
2006
- 2006-12-07 IL IL179924A patent/IL179924A0/en unknown
- 2006-12-27 NO NO20066010A patent/NO20066010L/no not_active Application Discontinuation
-
2009
- 2009-02-23 HR HR20090112T patent/HRP20090112T3/xx unknown
- 2009-03-31 CY CY20091100373T patent/CY1108942T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20066010L (no) | 2006-12-27 |
| US20080027074A1 (en) | 2008-01-31 |
| EP1771415B1 (en) | 2009-01-07 |
| US7678800B2 (en) | 2010-03-16 |
| KR20070036061A (ko) | 2007-04-02 |
| AU2005263324A1 (en) | 2006-01-26 |
| CA2570805A1 (en) | 2006-01-26 |
| ES2317266T3 (es) | 2009-04-16 |
| BRPI0512073A (pt) | 2008-02-06 |
| JP2008506640A (ja) | 2008-03-06 |
| SI1771415T1 (sl) | 2009-04-30 |
| UA82610C2 (uk) | 2008-04-25 |
| RS50804B (sr) | 2010-08-31 |
| AR052308A1 (es) | 2007-03-14 |
| DK1771415T3 (da) | 2009-02-23 |
| CN1972911A (zh) | 2007-05-30 |
| DE602005012272D1 (de) | 2009-02-26 |
| PL1771415T3 (pl) | 2009-06-30 |
| EA011418B1 (ru) | 2009-02-27 |
| EP1771415A1 (en) | 2007-04-11 |
| CA2570805C (en) | 2010-08-24 |
| JP4865710B2 (ja) | 2012-02-01 |
| CY1108942T1 (el) | 2014-07-02 |
| PT1771415E (pt) | 2009-03-16 |
| IL179924A0 (en) | 2007-05-15 |
| ZA200610162B (en) | 2008-06-25 |
| WO2006007843A1 (en) | 2006-01-26 |
| MXPA06015201A (es) | 2007-03-15 |
| EA200602180A1 (ru) | 2007-04-27 |
| ATE420071T1 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090112T3 (en) | 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence | |
| MA28279A1 (fr) | Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2 | |
| ATE496620T1 (de) | 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren | |
| MXJL06000006A (es) | Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre. | |
| MY129796A (en) | Novel anti-inflammatory androstane derivatives | |
| NO20060774L (no) | Kinolin- og kinazolinderivater som har affinitet for 5HT1-typereseptorer | |
| SE0302487D0 (sv) | Novel compounds | |
| GEP20084360B (en) | Substituted quinoline compounds | |
| TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| SE0202463D0 (sv) | Novel compounds | |
| GEP20094780B (en) | Prostaglandin nitrooxyderivatives | |
| NO20045281L (no) | Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer | |
| NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
| DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
| GEP20135883B (en) | Iminopyridine derivatives and usage thereof | |
| NO20071922L (no) | Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| HUP0100621A2 (hu) | Monoamin oxidáz inhibitor hatású vegyületek és h5-HT1B antagonista vagy részleges agonista hatású vegyületek kombinációját tartalmazó gyógyászati készítmények | |
| ATE417856T1 (de) | Motilidverbindungen | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer | |
| SE0202461D0 (sv) | Novel compounds | |
| DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
| DE60216142D1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
| ATE392644T1 (de) | Alpha-(1' -hydroxyalkyl)acrylate enthaltende beschichtungsmassen | |
| ATE293591T1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide |